SCHEMBL30989970

SCHEMBL30989970

CCN(Cc1ccccc1F)C(=O)c1cc(Cl)cnc1OC

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 3/20 0.44
▸ SMN1; SMN2 Q16637 3/20 0.43
▸ TP53 P04637 2/20 0.43
▸ TSPO P30536 1/20 0.41
▸ ROCK2 O75116 1/20 0.41
▸ ROCK1 Q13464 1/20 0.41
▸ ALOX5AP P20292 1/20 0.38
▸ FEN1 P39748 1/20 0.38
▸ ALDH1A1 P00352 4/20 0.38
▸ KDM4E B2RXH2 4/20 0.38
▸ L3MBTL1 Q9Y468 2/20 0.38
▸ MEN1 O00255 2/20 0.38
▸ KMT2A Q03164 2/20 0.38
▸ MAPK1 P28482 1/20 0.38
▸ HTT P42858 1/20 0.38
▸ NPSR1 Q6W5P4 2/20 0.38
▸ PTGER4 P35408 1/20 0.38
▸ HSD17B10 Q99714 1/20 0.38
▸ TSHR P16473 1/20 0.37
▸ CHRM5 P08912 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30989832 0.82 TSPO (0.43) MAPTTP53TSPOROCK2ROCK1
SCHEMBL30989973 0.79 RIPK1 (0.44) MAPTALDH1A1MEN1KMT2AGPBAR1
SCHEMBL30989967 0.79 RIPK1 (0.44) MAPTALDH1A1MEN1KMT2AGPBAR1
SCHEMBL30989879 0.77 LMNA (0.55) MAPTROCK2ROCK1ALDH1A1MEN1
SCHEMBL30989786 0.77 RXFP1 (0.45) MAPTALDH1A1MEN1KMT2AMAPK1
SCHEMBL30989882 0.76 MEN1 (0.48) MAPTROCK2ROCK1ALDH1A1KDM4E
SCHEMBL30989921 0.75 RIPK1 (0.45) MAPTALDH1A1KDM4EL3MBTL1GPBAR1
SCHEMBL30989898 0.74 GPBAR1 (0.42) MAPTALDH1A1L3MBTL1MEN1KMT2A
SCHEMBL30989930 0.73 HSP90AA1 (0.52) TP53ROCK2ROCK1ALDH1A1MEN1
SCHEMBL25228040 0.69 GPBAR1 (0.43) SMN1; SMN2MEN1KMT2AMAPK1PTGER4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4612131-A1 NICOTINAMIDE DERIVATIVES FOR USE IN TREATING DISORDERS ASSOCIATED WITH KCNK13 ACTIVITY Cerevance, Inc. (US) 2025-09-10 — — EP disclosed
WO-2024095003-A1 NICOTINAMIDE DERIVATIVES FOR USE IN TREATING DISORDERS ASSOCIATED WITH KCNK13 ACTIVITY Cerevance, Inc. (US) 2024-05-10 — — WO disclosed
Send feedback